PBS and WETA Caregiving Documentary by Executive Producer Bradley Cooper Now Available to Stream

Caregiving, Funded in Part by Lead and Founding Sponsor Otsuka, Underscores the Urgent Need for Systemic Reform and Sustainable Support for Family Caregivers PRINCETON, N.J.–(BUSINESS WIRE)–Otsuka America Pharmaceutical, Inc., the lead, founding sponsor of a new PBS and WETA documentary created with executive producer and award-winning actor Bradley Cooper, announces that Caregiving is now available … [Read more…]

Novocure Announces Upcoming Investor Events

BAAR, Switzerland–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that management will participate in two upcoming investor events. PANOVA-3 Investor Event, May 31, 2025: Novocure will host investors on Saturday, May 31 at 8:00 p.m. ET / 7:00 p.m. CT in Chicago to review data from the successful Phase 3 PANOVA-3 clinical trial in unresectable, locally advanced … [Read more…]

3D Investment Partners Recommends Toho Holdings Shareholders Vote Against the Reappointment of CEO Hiromi Edahiro, and Outside Director Yoshiaki Kamoya and Hidehito Kotani at the Company’s 77th Annual General Meeting

Repeated scandals, an attitude that is suspected as concealment and a lack of succession planning at Toho HD indicate its serious breakdown in corporate governance The Board of Directors continues to reject reasonable proposals for operational improvement, obstructing the Company’s path to sustainable value creation The persistent failure to address compliance issues risks alienating its … [Read more…]

Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences

MARSEILLE, France–(BUSINESS WIRE)–#IRConferences–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team will present and host 1×1 meetings at the upcoming investor conferences, detailed below. Jefferies Global Healthcare Conference Dates: June 3 – 5 2025 | New York, USA The executive team will … [Read more…]

Quadria Capital Closes Oversubscribed US$1 Billion Fund III to Advance Healthcare Transformation Across Asia

Fund close exceeds initial target despite a challenging fundraising environment, reflecting strong investor confidence in India and Southeast Asia healthcare Existing investors increased commitment amount by an average of 80% New capital raised from blue-chip global institutions, alongside a significant rise in Asian investor participation HO CHI MINH CITY, Vietnam–(BUSINESS WIRE)–Quadria Capital, Asia’s premier healthcare-focused … [Read more…]

Digital Therapeutics Market Analysis and Forecasts, 2025-2035 – Continuous Technological Advancements and Increasing Demand for Cost-Effective Solutions Bolster Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Digital Therapeutics Market – A Global and Regional Analysis: Focus on Product Type, Application, Sales Channel, and Country – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. The global digital therapeutics market includes clinically validated software and devices that are evidence-based. These tools are intended for the treatment of a … [Read more…]

Poxel Announces Positive Preclinical Data for PXL065 in Hypertrophic Cardiomyopathy To Be Presented at the ESC Congress 2025

PXL065 demonstrated significant benefits in a HCM mouse model preventing pathological myocardial remodeling, including hypertrophy and fibrosis in the heart Presentation of detailed results from preclinical study on Sept 1st, 2025, 11:15 am CEST, at the European Society of Cardiology 2025 Findings support the clinical development of PXL065 as a potential disease- modifying treatment for … [Read more…]

VISTA Inhibitor Clinical Trials Market Insights and Drug Development Opportunities Report 2025-2028 Featuring Aurigene, Curis, Hummingbird Bioscience, Kineta, PharmAbcine, Sensei Biotherapeutics – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “VISTA Inhibitor Clinical Trials, Drug Development Opportunities & Patent Insight 2025” report has been added to ResearchAndMarkets.com’s offering. The landscape of cancer immunotherapy has witnessed remarkable transformations in recent years, with immune checkpoint inhibitors revolutionizing treatment approaches for various malignancies. With the massive success of first generation immune checkpoint inhibitors, such as pembrolizumab … [Read more…]

Stride and UNITY Fitness Announce Market-First Partnership, Redefining Personal Health Optimisation in Canada

Industry-leading debut of Canada’s most advanced health and wellness model that combines advanced health diagnostics with a premium fitness and recovery membership experience. TORONTO–(BUSINESS WIRE)–In a bold move set to reshape Canada’s health and wellness landscape, Stride — the digital-first leader in health optimisation — has partnered with UNITY Fitness Harbourfront, Toronto’s destination for holistic … [Read more…]

Ardent Health Partners, Inc. Updates Name to Ardent Health, Inc.

BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that its board of directors voted to change the Company’s name to Ardent Health, Inc., effective June 3, 2025. The updated name aligns the Company’s legal name … [Read more…]